A Metabolic Signature of Hereditary Transthyretin Amyloidosis: A Pilot Study

A Metabolic Signature of Hereditary Transthyretin Amyloidosis: A Pilot Study

Hereditary transthyretin amyloidosis is the most common form of hereditary amyloidosis, with an autosomal dominant inheritance and a variable penetrance. ATTRv amyloidosis can present as a progressive, axonal sensory autonomic and motor neuropathy or as an infiltrative cardiomyopathy. The definition...

Full description

Bibliographic Details
Main Authors:	Marco Luigetti, Valeria Guglielmino, Angela Romano, Maria Ausilia Sciarrone, Francesca Vitali, Andrea Sabino, Jacopo Gervasoni, Aniello Primiano, Lavinia Santucci, Rossana Moroni, Guido Primiano
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	amyloidosis ATTRv biomarkers metabolites tryptophan palmitic acid
Online Access:	https://www.mdpi.com/1422-0067/23/24/16133

Similar Items

Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications
by: Marco Luigetti, et al.
Published: (2022-12-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
by: Hiroki Yamaguchi, et al.
Published: (2022-03-01)

Trajectories of Kidney Function in Patients with ATTRv Treated with Gene Silencers
by: Marco Luigetti, et al.
Published: (2022-11-01)

Clinical model for Hereditary Transthyretin Amyloidosis age of onset prediction
by: Maria Pedroto, et al.
Published: (2023-07-01)

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus
by: M. Grandis, et al.
Published: (2020-12-01)

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
by: Laura Obici, et al.
Published: (2023-07-01)

Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression
by: David Adams, et al.
Published: (2021-10-01)

Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis
by: Maria do Carmo Vilas-Boas, et al.
Published: (2020-11-01)

Corrigendum: Clinical 3-D gait assessment of patients with polyneuropathy associated with hereditary transthyretin amyloidosis
by: Maria do Carmo Vilas-Boas, et al.
Published: (2022-08-01)

Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation
by: Stefano Tozza, et al.
Published: (2023-02-01)

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
by: Morie Gertz, et al.
Published: (2020-09-01)

Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage
by: Junhui Shen, et al.
Published: (2022-09-01)

Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series
by: Maria do Carmo Vilas-Boas, et al.
Published: (2022-07-01)

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy
by: Loris Poli, et al.
Published: (2023-10-01)

Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation
by: Xujun Chu, et al.
Published: (2022-10-01)

Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M
by: Hsueh-Wen Hsueh, et al.
Published: (2022-01-01)

Transthyretin Gene Variants and Associated Phenotypes in Danish Patients with Amyloid Cardiomyopathy
by: Torsten B. Rasmussen, et al.
Published: (2022-01-01)

High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients
by: Hendrea S. A. Tingen, et al.
Published: (2024-01-01)

Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria
by: Teodora Chamova, et al.
Published: (2022-04-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
by: Faruk Uğur Doğan, et al.
Published: (2019-03-01)

Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
by: Massimo Russo, et al.
Published: (2020-12-01)

Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
by: Guido Primiano, et al.
Published: (2021-11-01)

Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy
by: Vincenzo Di Stefano, et al.
Published: (2023-05-01)

Ocular Morpho-Functional Evaluation in ATTRv Pre-Symptomatic Carriers: A Case Series
by: Martina Maceroni, et al.
Published: (2023-01-01)

A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
by: Ivan Urits, et al.
Published: (2020-08-01)

Hereditary transthyretin amyloidosis: a case report
by: Angela Lee, et al.
Published: (2022-06-01)

Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis
by: Emily R. Soper, et al.
Published: (2021-01-01)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
by: Ando Yukio, et al.
Published: (2013-02-01)

Ocular Involvement in Hereditary Amyloidosis
by: Angelo Maria Minnella, et al.
Published: (2021-06-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives
by: Marques JH, et al.
Published: (2022-07-01)

Advances in the treatment of hereditary transthyretin amyloidosis: A review
by: Morie A. Gertz, et al.
Published: (2019-09-01)

Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis
by: Domenico Plantone, et al.
Published: (2023-09-01)

Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area
by: Massimo Russo, et al.
Published: (2021-04-01)

Quantitative Sensory Testing in Late-Onset ATTRv Presymptomatic Subjects: A Single Center Experience
by: Stefano Tozza, et al.
Published: (2022-11-01)

A clinical case of hereditary transthyretin amyloidosis. Case report
by: Anastasia A. Shoshina, et al.
Published: (2023-05-01)

Portable RGB-D Camera-Based System for Assessing Gait Impairment Progression in ATTRv Amyloidosis
by: Maria do Carmo Vilas-Boas, et al.
Published: (2022-10-01)

Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
by: Xinyue He, et al.
Published: (2022-09-01)